Immunovia Publ (Sweden) Market Value
| IMMNOV Stock | SEK 0.36 0.02 5.88% |
| Symbol | Immunovia |
Immunovia Publ 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immunovia Publ's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immunovia Publ.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in Immunovia Publ on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Immunovia publ AB or generate 0.0% return on investment in Immunovia Publ over 90 days. Immunovia Publ is related to or competes with Oncopeptides, Hansa Biopharma, Cantargia, and Camurus AB. Immunovia AB , a molecular diagnostics company, develops and commercializes diagnostic tools for cancer and autoimmune d... More
Immunovia Publ Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immunovia Publ's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immunovia publ AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.29) | |||
| Maximum Drawdown | 18.85 | |||
| Value At Risk | (5.80) | |||
| Potential Upside | 4.94 |
Immunovia Publ Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunovia Publ's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immunovia Publ's standard deviation. In reality, there are many statistical measures that can use Immunovia Publ historical prices to predict the future Immunovia Publ's volatility.| Risk Adjusted Performance | (0.27) | |||
| Jensen Alpha | (1.08) | |||
| Total Risk Alpha | (0.69) | |||
| Treynor Ratio | (1.83) |
Immunovia publ AB Backtested Returns
Immunovia publ AB holds Efficiency (Sharpe) Ratio of -0.29, which attests that the entity had a -0.29 % return per unit of risk over the last 3 months. Immunovia publ AB exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immunovia Publ's Risk Adjusted Performance of (0.27), standard deviation of 3.62, and Market Risk Adjusted Performance of (1.82) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.63, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Immunovia Publ's returns are expected to increase less than the market. However, during the bear market, the loss of holding Immunovia Publ is expected to be smaller as well. At this point, Immunovia publ AB has a negative expected return of -0.94%. Please make sure to check out Immunovia Publ's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Immunovia publ AB performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.83 |
Very good predictability
Immunovia publ AB has very good predictability. Overlapping area represents the amount of predictability between Immunovia Publ time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immunovia publ AB price movement. The serial correlation of 0.83 indicates that around 83.0% of current Immunovia Publ price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.83 | |
| Spearman Rank Test | 0.89 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Immunovia publ AB lagged returns against current returns
Autocorrelation, which is Immunovia Publ stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Immunovia Publ's stock expected returns. We can calculate the autocorrelation of Immunovia Publ returns to help us make a trade decision. For example, suppose you find that Immunovia Publ has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Immunovia Publ regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Immunovia Publ stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Immunovia Publ stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Immunovia Publ stock over time.
Current vs Lagged Prices |
| Timeline |
Immunovia Publ Lagged Returns
When evaluating Immunovia Publ's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Immunovia Publ stock have on its future price. Immunovia Publ autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Immunovia Publ autocorrelation shows the relationship between Immunovia Publ stock current value and its past values and can show if there is a momentum factor associated with investing in Immunovia publ AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Immunovia Stock
Immunovia Publ financial ratios help investors to determine whether Immunovia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Immunovia with respect to the benefits of owning Immunovia Publ security.